[The diagnostic value of virus serology in patients with non-ischemic systolic heart failure and parvovirus B19 infection].

Autor:	Nowalany-Kozielska E; II Katedra i Oddział Kliniczny Kardiologii Wydziału Lekarskiego z Oddziałem Lekarsko-Dentystycznym w Zabrzu, SUM., Kozieł M, Domal-Kwiatkowska D, Dworniczak S, Wojnicz R, Wojciechowska C, Jachec W, Kawecki D, Smolik S, Weglarz L, Kozielski J
Jazyk:	polština
Zdroj:	Wiadomosci lekarskie (Warsaw, Poland : 1960) [Wiad Lek] 2012; Vol. 65 (4), pp. 211-5.
Abstrakt:	Introduction: We determined retrospective analysis of the diagnostic value of virus serology in patients with non-ischemic systolic heart failure and parvovirus B19 infection. Material and Methods: Virus serology and endomyocardial biopsy were performed in 31 patients with non-ischemic systolic heart failure hospitalized from 2001 to 2006 in our clinic. Results: The serum specimens from 31 patients were tested for IgM and IgG antibody against parvovirus B19. IgM antibodies were identified in 3 patients and IgG antibodies were identified in 23 patients. All of the patients underwent endomyocardial biopsy which revealed chronic active myocarditis in 10 patients (32.4%), chronic persistent myocarditis in 14 patients (45.1%) and no myocarditis in 7 patients (22.5%). Conclusions: Virus serology has no relevance for the diagnosis of non-ischemic systolic heart failure caused by parvovirus B19 infection. The result of serological tests are positive more frequently than the biopsy specimens results.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu